Form 8-K CHARLES RIVER LABORATORI For: Nov 07

Go back to Form 8-K CHARLES RIVER LABORATORI For: Nov 07

Charles River Labs (CRL) PT Raised to $147 at RBC Capital

November 8, 2018 7:01 AM EST

RBC Capital analyst George Hill raised the price target on Charles River Labs (NYSE: CRL) to $147.00 (from $131.00) while maintaining an Outperform rating following Q3 results, which beat on EPS and revenue though margin missed.

"We believe the miss was largely a... More